1. Executive Summary
2. Global Cervical Dystonia Management Market Introduction
2.1. Global Cervical Dystonia Management Market – Taxonomy
2.2. Global Cervical Dystonia Management Market –Definitions
2.2.1. Route of Administration
2.2.2. Drug Class
2.2.3. Distribution Channel
3. Global Cervical Dystonia Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cervical Dystonia Management Market Dynamic Factors - Impact Analysis
3.6. Global Cervical Dystonia Management Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Cervical Dystonia Management Market –Trends
4. Global Cervical Dystonia Management Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cervical Dystonia Management Market, By Route of Administration, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Oral
5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Intravenous
5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Cervical Dystonia Management Market Forecast, By Drug Class, 2013 - 2017 and Forecast, 2018 – 2024
6.1. Dopaminergic drugs
6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Anti-cholinergic drugs
6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. GABA Agonists
6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Anti Convulsants
6.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Cervical Dystonia Management Market Forecast, By End User, 2013 - 2017 and Forecast, 2018 – 2024
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Cervical Dystonia Management Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cervical Dystonia Management Market - Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Region, 2018 – 2024
9. North America Cervical Dystonia Management Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Route of Administration Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Oral
9.1.2. Intravenous
9.2. Drug Class Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Dopaminergic drugs
9.2.2. Anti-cholinergic drugs
9.2.3. GABA Agonists
9.2.4. Anti Convulsants
9.3. End User Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospital pharmacies
9.3.2. Retail pharmacies
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cervical Dystonia Management Market - Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
9.6. North America Cervical Dystonia Management Market Dynamics – Trends
10. Europe Cervical Dystonia Management Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Route of Administration Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Oral
10.1.2. Intravenous
10.2. Drug Class Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Dopaminergic drugs
10.2.2. Anti-cholinergic drugs
10.2.3. GABA Agonists
10.2.4. Anti Convulsants
10.3. End User Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospital pharmacies
10.3.2. Retail pharmacies
10.3.3. Others
10.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cervical Dystonia Management Market - Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
10.6. Europe Cervical Dystonia Management Market Dynamics – Trends
11. Asia-Pacific Cervical Dystonia Management Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Route of Administration Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Oral
11.1.2. Intravenous
11.2. Drug Class Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Dopaminergic drugs
11.2.2. Anti-cholinergic drugs
11.2.3. GABA Agonists
11.2.4. Anti Convulsants
11.3. End User Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospital pharmacies
11.3.2. Retail pharmacies
11.3.3. Others
11.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cervical Dystonia Management Market - Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
11.6. Asia-Pacific Cervical Dystonia Management Market Dynamics – Trends
12. Latin America Cervical Dystonia Management Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Route of Administration Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Oral
12.1.2. Intravenous
12.2. Drug Class Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Dopaminergic drugs
12.2.2. Anti-cholinergic drugs
12.2.3. GABA Agonists
12.2.4. Anti Convulsants
12.3. End User Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospital pharmacies
12.3.2. Retail pharmacies
12.3.3. Others
12.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cervical Dystonia Management Market - Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
12.6. Latin America Cervical Dystonia Management Market Dynamics – Trends
13. Middle East and Africa Cervical Dystonia Management Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
13.1. Route of Administration Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Oral
13.1.2. Intravenous
13.2. Drug Class Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Dopaminergic drugs
13.2.2. Anti-cholinergic drugs
13.2.3. GABA Agonists
13.2.4. Anti Convulsants
13.3. End User Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospital pharmacies
13.3.2. Retail pharmacies
13.3.3. Others
13.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cervical Dystonia Management Market - Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
13.6. MEA Cervical Dystonia Management Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Route of Administration & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Ashland Inc.(U.S.)
14.2.2. AkzoNobel (Netherlands)
14.2.3. The DOW Chemical Company (U.S.)
14.2.4. Archer Daniels Midland Company(U.S.)
14.2.5. Associated British Foods PLC (UK)
14.2.6. Colorcon, Inc.(U.S.)
14.2.7. BASF SE(Germany)
14.2.8. Evonik Industries AG (Germany)
14.2.9. Innophos Holdings Inc. (U.S.)
14.2.10. J.M. Huber Corporation (U.S.)
14.2.11. FMC Corporation (U.S.)
14.2.12. Roquette Group (France)
14.2.13. Croda International PLC (UK)
14.2.14. Merck KGaA (Germany)
14.2.15. Lubrizol Corporation (U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms